Your search

Filter the results

By type of result

By number of elements

31 results

Team 1 - Liver Cancer and Tumor Invasion (25 February 2022)

Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. It is the 6th most frequent cancer worldwide and the 2nd leading cause of cancer-related death. The overall poor prognosis of HCC is due ... Team 1 results from the gathering of scientists with the aim of performing both fundamental and translational research in the field of liver carcinogenesis. ... Team 1 - Liver Cancer and Tumor Invasion

Organization of the Unit (10 July 2020)

The BaRITOn unit is composed of three INSERM teams. Team 1 - Liver cancer and tumor invasion Team 2 - Helicobacter infection: Inflammation and Cancer Team 3 - Oncogenesis of cutaneous ... Cancer, invasion, liver cancer, actin cytoskeleton, invadosomes, metastases, gastric cancer, gastric MALT lymphoma, cancer stem cells, toxins, Helicobacter pylori, Cutaneous lymphomas, telomerase

Team 1 awarded FRM label 2018 (05 September 2018)

The "Liver Cancer and Tumor Invasion" team from BaRITOn led by Violaine Moreau and Frédéric Saltel, has just been awarded the "FRM Team of the Fondation de la Recherche Médicale" label.

Group M. Bouchecareilh (25 February 2022)

involvement in liver cancer progression   News • Marion organized the first symposium on "Liver rare diseases" in Bordeaux, France / 8 February, 2019. • Marion presented her data at the 6th Alpha-1 Global ... Our research focuses on the identification of biomarkers and new therapeutic targets involved in liver physiopathology (Rare disease: Alpha 1-Antitrypsin Deficiency and Cancer: Hepatocellular

Presentation of the unit (22 May 2017)

Cancer, invasion, liver cancer, actin cytoskeleton, invadosomes, small GTPases, metastases, Rho GTPases, collagen, DDR, gastric cancer, gastric MALT lymphoma, cancer stem cells, toxins

New publication of Team 1 in Nature Cell Biology (21 September 2020)

metalloproteases but whether other enzymes are required is unclear. Here, we show that GALA induces glycosylation of ER-resident Calnexin (Cnx) in breast and liver cancer. Glycosylated Cnx and its partner ERp57

V. Moreau received an FRM award for BaRITOn Team #1 (11 November 2019)

. The "Liver Cancer and Tumor Invasion" team from BaRITOn led by Violaine Moreau and Frédéric Saltel, has been awarded the "FRM Team of the Fondation de la Recherche Médicale" label. This prestigious label

Structure of the unit (29 November 2020)

in human cancer translational research. Indeed, the unit originated in 2016 from the merger of 3 pre-existing labs: INSERM U1053 “Pathophysiology of Liver Cancer”, INSERM U853 “Helicobacter infection

Postdoctoral position in Team 1 (01 February 2021)

We are seeking applications from strong candidates for a postdoctoral fellowship position in liver cancer (hepatocellular carcinoma, HCC) invasion at Bordeaux university, U1053, Bariton. Our lab

Translational Research (29 November 2020)

to : • identify biomarkers of Sorafenib efficiency (JF. Blanc/F. Saltel)   People Frederic SALTEL, DR Inserm Anne-Aurélie RAYMOND, IR Inserm Jean-Frédéric BLANC, PU-PH - Liver Oncologist (Bordeaux) Charles ... We develop translational projects in close collaboration with clinicians specialized in liver diseases.